DE69100954T2 - Lagerstabile orale Glucosaminsulfat-Dosisformen und Verfahren zu deren Herstellung. - Google Patents

Lagerstabile orale Glucosaminsulfat-Dosisformen und Verfahren zu deren Herstellung.

Info

Publication number
DE69100954T2
DE69100954T2 DE91850031T DE69100954T DE69100954T2 DE 69100954 T2 DE69100954 T2 DE 69100954T2 DE 91850031 T DE91850031 T DE 91850031T DE 69100954 T DE69100954 T DE 69100954T DE 69100954 T2 DE69100954 T2 DE 69100954T2
Authority
DE
Germany
Prior art keywords
oral
methods
preparation
glucosamine sulfate
storage forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE91850031T
Other languages
English (en)
Other versions
DE69100954D1 (de
Inventor
Harry Byron Demopoulos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Health Maintenance Programs Inc
Original Assignee
Health Maintenance Programs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Health Maintenance Programs Inc filed Critical Health Maintenance Programs Inc
Publication of DE69100954D1 publication Critical patent/DE69100954D1/de
Application granted granted Critical
Publication of DE69100954T2 publication Critical patent/DE69100954T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE91850031T 1990-02-22 1991-02-12 Lagerstabile orale Glucosaminsulfat-Dosisformen und Verfahren zu deren Herstellung. Expired - Fee Related DE69100954T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48357290A 1990-02-22 1990-02-22

Publications (2)

Publication Number Publication Date
DE69100954D1 DE69100954D1 (de) 1994-02-24
DE69100954T2 true DE69100954T2 (de) 1994-05-05

Family

ID=23920608

Family Applications (1)

Application Number Title Priority Date Filing Date
DE91850031T Expired - Fee Related DE69100954T2 (de) 1990-02-22 1991-02-12 Lagerstabile orale Glucosaminsulfat-Dosisformen und Verfahren zu deren Herstellung.

Country Status (5)

Country Link
EP (1) EP0444000B1 (de)
JP (1) JP3135273B2 (de)
AT (1) ATE99946T1 (de)
CA (1) CA2035841C (de)
DE (1) DE69100954T2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH690719A5 (it) * 1996-08-19 2000-12-29 Rotta Res B V Amsterdam Swiss Procedimento per la preparazione di sali misti della glucosamina.
TWI230618B (en) * 1998-12-15 2005-04-11 Gilead Sciences Inc Pharmaceutical compositions of 9-[2-[[bis[(pivaloyloxy)methyl]phosphono]methoxy]ethyl]adenine and tablets or capsules containing the same
WO2001001993A1 (en) * 1999-07-02 2001-01-11 Greither, Peter A formulation of glucosamine sulphate
WO2001001992A1 (en) * 1999-07-02 2001-01-11 Sca Lohnherstellungs Ag A solid formulation of glucosamine sulphate
US20030235629A1 (en) * 1999-11-06 2003-12-25 Janmarie Hornack Dietary supplement containing alkaline electrolyte buffers
JP2002265365A (ja) * 2001-03-08 2002-09-18 Koyo Chemical Kk 好中球機能抑制剤
WO2003049696A2 (en) * 2001-12-07 2003-06-19 Cargill, Incorporated Glucosamine organic acid adducts
ES2255829B1 (es) 2004-08-06 2007-08-16 Bioiberica, S.A. Nuevo uso de sales de glucosamina.
US7943598B2 (en) 2004-08-06 2011-05-17 Bioiberica, S.A. Use of organic glucosamine salts
DK2429500T3 (en) 2009-05-13 2015-03-09 Wyeth Llc Process for the stabilization of any supplements comprehensive glucosamine
EP3499089B1 (de) 2017-12-14 2023-03-08 SFS Group International AG Kugelumlenkung eines kugelgewindetriebes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
US4642237A (en) * 1985-04-24 1987-02-10 Pennwalt Corporation Stable oxidant alpha-amylase concentrates for use in baking
DE3532081A1 (de) * 1985-09-09 1987-03-12 Orion Yhtymae Oy Mischsalze von glucosaminsulfat und verfahren zu ihrer herstellung
JPS6396126A (ja) * 1986-10-13 1988-04-27 Taisho Pharmaceut Co Ltd 安定化組成物

Also Published As

Publication number Publication date
EP0444000B1 (de) 1994-01-12
CA2035841A1 (en) 1991-08-23
EP0444000A3 (en) 1991-10-23
ATE99946T1 (de) 1994-01-15
JPH0687762A (ja) 1994-03-29
DE69100954D1 (de) 1994-02-24
JP3135273B2 (ja) 2001-02-13
EP0444000A2 (de) 1991-08-28
CA2035841C (en) 1996-02-13

Similar Documents

Publication Publication Date Title
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
DE68904326T3 (de) Physiologisch aktive Substanzen enthaltende Mikrosphären des Polymilchsäuretyps sowie Verfahren zu deren Herstellung.
ATE82118T1 (de) Feste und poroese einheitsform, enthaltend mikropartikel und/oder nanopartikel und verfahren zu ihrer herstellung.
AT380015B (de) Verfahren zur herstellung von 1,5-benzothiazepinderivaten sowie von deren saeureadditionssalzen
DE69100954T2 (de) Lagerstabile orale Glucosaminsulfat-Dosisformen und Verfahren zu deren Herstellung.
ATE68704T1 (de) Gegenueber lichteinfluss stabilisiertes nifedipin- konzentrat und verfahren zu seiner herstellung.
DE69212968T2 (de) Herstellung von Ethylendiamintriessigsäure
EP0293751A3 (en) Taurohyodeoxycholic acid for the therapy of calculosis of the biliary tract and of biliary dyspepsia
DE69106594T2 (de) Herstellung von Zitronensäure.
ATE38836T1 (de) Substituierte benzopyrane, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln.
EP0146863A3 (de) Orale retardierte Acetylsalicylsäureformulierungen
DE69213183T2 (de) N'-Cyanomethylethylendiamin-N,N'-Diessigsäure, ihre Salze und ihre Herstellung
DE3883235D1 (de) Weisses desodorierungsmittel und verfahren zu seiner herstellung.
IT1251226B (it) Composizioni farmaceutiche contenenti clozapina, loro preparazione e loro impiego
DE69016087T2 (de) Stabile Lösungen von Rebeccamycinderivaten sowie deren Herstellung.
ATA272382A (de) Verfahren zur herstellung von neuen 3,7-diazabicyclo/3,3,1/ nonanderivaten, deren stereoisomren und physiologisch vertraeglichen saeureadditionssalzen
ATE6031T1 (de) Arzneimittel zur oralen verabreichung und verfahren zu seiner herstellung.
ATE1442T1 (de) Pharmazeutisches mittel, enthaltend all-e- oder 13-z-7,8-dehydro-retinsaeure und verfahren zu seiner herstellung.
DE3675722D1 (de) 4-alkoxy-3-pyrrolin-2-on-1-yl-essigsaeurealkyl- bzw. -benzylester sowie deren herstellung.
DK0520372T3 (da) Inositol-phosphat-analoger som calciumantagonistiske stoffer
DE3773716D1 (de) Verfahren zur herstellung von monosodiumsalz und dessen monohydrat von 1-beta-d-arabinofuranosylcytosin-5'stearylphosphat und diese enthaltende pharmazeutische zusammensetzung.
DE69305250D1 (de) Herstellung von Alkandicarbonsäurederivaten
DE69812910T2 (de) Herstellung von ungesättigten verbindungen und deren carbonsäure-derivaten
DE3476520D1 (en) Use of a mixture of compounds for the manufacture of a composition for the treatment of buerger's disease
FR2607005B1 (fr) Compositions pharmaceutiques contenant de l'acide ursodesoxycholique

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee